Cargando…
2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334165/ http://dx.doi.org/10.1186/1546-0096-6-S1-S1 |
| _version_ | 1782230604517998592 |
|---|---|
| author | Yokota, S Imagawa, T Miyamae, T Kasai, K Mori, M Nishimoto, N Kishimoto, T |
| author_facet | Yokota, S Imagawa, T Miyamae, T Kasai, K Mori, M Nishimoto, N Kishimoto, T |
| author_sort | Yokota, S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3334165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33341652012-04-24 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) Yokota, S Imagawa, T Miyamae, T Kasai, K Mori, M Nishimoto, N Kishimoto, T Pediatr Rheumatol Online J Oral Presentation BioMed Central 2008-09-15 /pmc/articles/PMC3334165/ http://dx.doi.org/10.1186/1546-0096-6-S1-S1 Text en Copyright ©2008 Yokota et al; licensee BioMed Central Ltd. |
| spellingShingle | Oral Presentation Yokota, S Imagawa, T Miyamae, T Kasai, K Mori, M Nishimoto, N Kishimoto, T 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) |
| title | 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) |
| title_full | 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) |
| title_fullStr | 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) |
| title_full_unstemmed | 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) |
| title_short | 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA) |
| title_sort | 2.1 long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (jia) |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334165/ http://dx.doi.org/10.1186/1546-0096-6-S1-S1 |
| work_keys_str_mv | AT yokotas 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia AT imagawat 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia AT miyamaet 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia AT kasaik 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia AT morim 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia AT nishimoton 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia AT kishimotot 21longtermsafetyandefficacyoftocilizumabinchildrenwithsystemicjuvenileidiopathicarthritisjia |